Overbought Stock Signal: UNCY
Report Date: 02-26-2024
Symbol: UNCY - Unicycive Therapeutics, Inc.
Sector:
Industry:
Overbought Stock Signal: UNCY
Unicycive Therapeutics, Inc. (UNCY)
4300 El Camino Real
Los Altos, CA 94022
Phone: 650 351 4495
Website: https://www.unicycive.com
CEO: Dr. Shalabh K. Gupta M.D., MPA
NASDAQ, NASDAQ Capital Market
Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.